---
title: "Atrium Therapeutics (RNA.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/RNA.US/norm.md"
symbol: "RNA.US"
name: "Atrium Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/RNA.US.md"
datetime: "2026-05-20T21:21:40.802Z"
locales:
  - [en](https://longbridge.com/en/quote/RNA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RNA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RNA.US/norm.md)
---

# Atrium Therapeutics (RNA.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.9724 | -1.88 | -1.26 | -1.21 | -0.4355 |
| ROE | -77.64% | - | -45.33% | -49.91% | 48.76% |
| 营业收入 | 19.64M | 859000.00 | 12.47M | 3.85M | 1.57M |
| 净利润 | -16.63M | -29.14M | -174.44M | -157.31M | -7.45M |
| 营业利润 | -17.28M | -29.10M | -188.81M | -171.14M | -7.45M |
| 毛利率 | 45.00% | -1563.33% | -1142.07% | -3490.46% | -301.46% |
| 净利率 | -84.71% | -3391.85% | -1398.33% | -4089.29% | -473.55% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 292.36M | 8.35M | 2.13B | 1.37B | - |
| 权益乘数 | 1.25 | -0.1332 | 1.13 | 1.15 | - |
| 每股净资产 | 13.69 | -4.04 | 12.85 | 9.87 | - |
| 资产周转率 | - | 2.40 | 0.0111 | 0.0079 | - |
| 现金及短投 | 267.85M | - | 1.88B | 1.18B | - |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 6.38M | 5.51M | 74.35M | 24.76M | - |
| 净债务 | -265.17M | 3.67M | -1.83B | -1.18B | 6.80M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -31.14M | -19.25M | -156.17M | -199.67M | -11.10M |
| 投资现金流 | -2.10M | -879000.00 | -587.93M | 185.49M | - |
| 融资现金流 | 301.50M | 20.13M | 850.37M | 3.77M | 11.10M |
| 自由现金流 | -34.31M | - | -86.62M | -54.00M | - |
| 现金流充裕率 | -1484.41% | -2190.22% | -21934.41% | -5972.66% | - |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -2.10M | -879000.00 | -712000.00 | -3.34M | - |